Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor Trials.
Sherry AD, Lin TA, McCaw ZR, Beck EJ, Kouzy R, Abi Jaoude J, Passy AH, Miller AM, Kupferman GS, Fuller CD, Thomas CR Jr, Koay EJ, Tang C, Msaouel P, Ludmir EB. Sherry AD, et al. Among authors: mccaw zr. Int J Radiat Oncol Biol Phys. 2024 Dec 1;120(5):1239-1244. doi: 10.1016/j.ijrobp.2024.05.033. Epub 2024 Sep 30. Int J Radiat Oncol Biol Phys. 2024. PMID: 39352322
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation.
Lin TA, McCaw ZR, Koong A, Lin C, Abi Jaoude J, Patel R, Kouzy R, El Alam MB, Sherry AD, Noticewala SS, Fuller CD, Thomas CR Jr, Sun R, Lee JJ, Lin R, Yuan Y, Shyr Y, Meirson T, Ludmir EB. Lin TA, et al. Among authors: mccaw zr. Clin Cancer Res. 2024 Oct 15;30(20):4791-4799. doi: 10.1158/1078-0432.CCR-24-0566. Clin Cancer Res. 2024. PMID: 39133081
Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials.
Sherry AD, Msaouel P, Kupferman GS, Lin TA, Abi Jaoude J, Kouzy R, El-Alam MB, Patel R, Koong A, Lin C, Passy AH, Miller AM, Beck EJ, Fuller CD, Meirson T, McCaw ZR, Ludmir EB. Sherry AD, et al. Among authors: mccaw zr. medRxiv [Preprint]. 2024 Jul 24:2024.07.23.24310891. doi: 10.1101/2024.07.23.24310891. medRxiv. 2024. PMID: 39108512 Free PMC article. Preprint.
Bayesian Interim Analysis and Efficiency of Phase III Randomized Trials.
Sherry AD, Msaouel P, Miller AM, Lin TA, Kupferman GS, Jaoude JA, Kouzy R, El-Alam MB, Patel R, Koong A, Lin C, Meirson T, McCaw ZR, Ludmir EB. Sherry AD, et al. Among authors: mccaw zr. medRxiv [Preprint]. 2024 Jun 28:2024.06.27.24309608. doi: 10.1101/2024.06.27.24309608. medRxiv. 2024. PMID: 38978666 Free PMC article. Preprint.
Unsupervised representation learning on high-dimensional clinical data improves genomic discovery and prediction.
Yun T, Cosentino J, Behsaz B, McCaw ZR, Hill D, Luben R, Lai D, Bates J, Yang H, Schwantes-An TH, Zhou Y, Khawaja AP, Carroll A, Hobbs BD, Cho MH, McLean CY, Hormozdiari F. Yun T, et al. Among authors: mccaw zr. Nat Genet. 2024 Aug;56(8):1604-1613. doi: 10.1038/s41588-024-01831-6. Epub 2024 Jul 8. Nat Genet. 2024. PMID: 38977853 Free PMC article.
Interpretation of long-term survival data from MONARCH 3. Letter to the Editor regarding "Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3" by M. P. Goetz et al.
Sherry AD, Lin TA, McCaw ZR, Ludmir EB. Sherry AD, et al. Among authors: mccaw zr. Ann Oncol. 2024 Aug;35(8):747-748. doi: 10.1016/j.annonc.2024.05.543. Epub 2024 Jun 3. Ann Oncol. 2024. PMID: 38838846 No abstract available.
85 results